Company: PRGO
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0001585364-25-000056
Chunk: 24

Company: PERRIGO Co plc
Filing Date: 2025-05-07
Form: 10-Q
Item: Item 1
Chunk 24
---
 and related consulting fees. The following reflects our restructuring activity (in millions):Three Months EndedMarch 29, 2025Supply Chain ReinventionHRA Pharma Integration Project EnergizeNutrition Network Optimization Other InitiativesTotalBeginning balance$2.3 $1.6 $27.9 $— $1.0 $32.8 Additional charges4.7 — 8.2 16.5 — 29.4 Payments(6.2)— (9.4)— (1.0)(16.6)Ending balance$0.8 $1.6 $26.7 $16.5 $— $45.6 Three Months EndedMarch 30, 2024Supply Chain ReinventionHRA Pharma Integration Project EnergizeOther InitiativesTotalBeginning balance$0.7 $6.8 2.9 $1.8 $12.2 Additional charges2.6 0.1 41.4 0.2 44.3 Payments(2.4)(0.3)(6.9)(1.1)(10.7)Non-cash adjustments— — (4.8)— (4.8)Ending balance$0.9 $6.6 $32.6 $0.9 $41.0 The charges incurred during the three months ended March 29, 2025 were primarily associated with employee separation costs as a result of actions taken to optimize our nutrition network. The charges incurred during the three months ended March 30, 2024 were primarily associated with actions taken on Project Energize activities associated with employee separation and consulting fees. Of the amount recorded during the three months ended March 29, 2025, $3.8 million was related to our CSCI segment and $20.1 million was related to our CSCA segment, and $5.5 million was related to our Unallocated segment. For CSCA, amounts were due primarily to Nutrition Network Optimization while CSCI and Unallocated segment amounts were due primarily to Project Energize. Of the amount recorded during the three months ended March 30, 2024, $15.5 million was related to our CSCI segment and $16.5 million was related to our CSCA 

24

Perrigo Company plc - Item 1Note 14

segment, and $12.3 million was related to our Un